On the 9th, PeopleBio broke through the "upper limit (the top of the daily price limit)" at the start of trading on news that it received an "unqualified" opinion on last year's business-year audit report.
As of 9:23 a.m. on the 9th, on the KOSDAQ market, PeopleBio was trading at 1,271 won, up 293 won (29.96%) from the previous session.
On the 7th, PeopleBio disclosed that it received an "unqualified" opinion from its external auditor on last year's business-year audit report. Along with this, it was removed from the existing Investment Risk Alert category in its former section and reclassified into the venture companies section.
PeopleBio plans to focus on improving profitability and stabilizing management. The company said, "We will work to restore market confidence and enhance corporate value by linking and integrating the Samsung-dong edge data center project and IT and AI-related businesses being pursued by major shareholder RealityGen with the AlzOn dementia diagnosis business."